Schumock Glen T, Pickard A Simon
Department of Pharmacy Systems, Outcomes & Policy, College of Pharmacy, University of Illinois at Chicago, 833 S Wood Street (MC 871), Chicago, IL 60612, USA.
J Comp Eff Res. 2018 Feb;7(2):177-180. doi: 10.2217/cer-2017-0057. Epub 2018 Feb 21.
Evidence from comparative effectiveness research (CER) and patient-centered outcomes research (PCOR) studies are increasingly available in the literature. However, there remain opportunities to better integrate that evidence into decision-making. An invitation-only conference held in January 2017, titled "Comparative Effectiveness and Patient-Centered Outcomes Research: Enhancing Uptake and Use by Patients, Clinicians and Payers", sought to identify and discuss both gaps in the uptake and use of CER/PCOR, and approaches to enhance the uptake and use of CER/PCOR evidence by patients, clinicians and payers. In this article, we summarize the conference proceedings, and highlight the themes and recommendations that resulted from the sessions. This paper also introduces other articles in this issue of CER from that conference.
比较效果研究（CER）和以患者为中心的结局研究（PCOR）的证据在文献中越来越多。然而，仍有机会将这些证据更好地整合到决策中。2017年1月举办了一场仅限受邀者参加的会议，题为“比较效果与以患者为中心的结局研究：提高患者、临床医生和支付方的采用率和使用率”，旨在识别和讨论CER/PCOR在采用和使用方面的差距，以及提高患者、临床医生和支付方采用和使用CER/PCOR证据的方法。在本文中，我们总结了会议议程，并突出了各场次会议产生的主题和建议。本文还介绍了该会议本期CER中的其他文章。
